Wanbury Ltd.
Snapshot View

View in App

Prices View details >>

43.50 -0.40 ▼-0.9%

27 January 2023, 02:06:54 PM
Volume: 11,489

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.wanbury.com
Market Cap 141.12 Cr.
Enterprise Value(EV) 199.84 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 22.87 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 1.88 Trailing Twelve Months Ending 2022-09
Industry PE 33.61 Trailing Twelve Months Ending 2022-09
Book Value / Share -10.02 Trailing Twelve Months Ending 2022-09
Price to Book Value -4.29 Calculated using Price: 43.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 3.27 Cr. 32,705,498 Shares
FaceValue 10
Company Profile
Wanbury was incorporated in 1990 as a private limited company under the name of Pearl Distributors Private Limited. The name of the company was changed to 'Pearl Organics Private Limited on January 17, 1991 and the company was converted into a public limited company on August 6, 1991.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.91%
1 Week
-4.19%
1 Month
-7.05%
3 Month
-36.22%
6 Month
-32.19%
1 Year
-44.41%
2 Year
-25.06%
5 Year
+0.93%
10 Year
+40.78%

Ratios View Details >>

9 years 2014-09 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%)
Return on Capital Employed (%) -31.06 13.85 15.27 70.48 -2.00 50.26 444.45 87.61 428.79
Return on Assets (%) -21.66 0.80 -1.82 15.57 -9.44 -9.00 23.10 -4.51 25.85

Balance Sheet View Details >>

Particulars 10 years 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds -192 -194 -189 -153 -185 -209 -143 -156 -23 -31
Non Curr. Liab. 312 298 251 160 106 130 108 84 11 10
Curr. Liab. 259 265 299 402 348 362 311 355 360 360
Minority Int. 27 27 27
Equity & Liab. 406 396 388 409 269 283 275 284 347 338
Non Curr. Assets 219 215 224 217 192 185 182 182 174 174
Curr. Assets 187 181 164 192 78 98 94 98 171 165
Misc. Exp. not W/O
Total Assets 406 396 388 409 269 283 275 284 347 338

Profit Loss View Details >>

Particulars 10 years 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 662 250 423 434 371 391 367 393 511 500
Other Income 11 6 1 90 77 12 46 5 5 4
Total Income 673 256 425 524 448 403 414 397 516 504
Total Expenditure -638 -229 -391 -415 -439 -378 -389 -377 -479 -476
PBIDT 35 28 34 108 9 25 25 20 37 28
Interest -48 -19 -32 -36 -31 -40 -33 -23 -21 -18
Depreciation -23 -5 -9 -10 -10 -10 -10 -10 -11 -12
Taxation -3 -1 0 0 0 0 0 0 0
Exceptional Items -89 83 76 76
PAT -128 3 -7 62 -32 -25 64 -13 81 75
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -128 3 -7 62 -32 -25 64 -13 81 75
Adjusted EPS -64 2 -4 27 -13 -10 26 -5 25 23

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 87 68 40 43 43 32 30 44 17 41
Cash Fr. Inv. -21 -6 -5 -20 -13 -1 -3 64 8 1
Cash Fr. Finan. -64 -71 -30 -28 -27 -33 -27 -108 -17 -29
Net Change 3 -9 5 -5 3 -2 0 0 7 13
Cash & Cash Eqvt 10 1 6 2 5 3 3 3 10 23

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 52.09 52.09 39.90 39.90 39.89 39.89 39.85 39.85 39.84
Public 47.91 47.91 60.10 60.10 60.11 60.11 60.15 60.15 60.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 76.76 76.76 76.76 76.76 76.76 76.76 76.74 76.74 0.00

Announcements View Details >>

Wed, 04 Jan 2023
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Wanbury Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Tue, 03 Jan 2023
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Wanbury Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Fri, 30 Dec 2022
Trading Window
Wanbury Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Technical Scans View Details >>

Wed, 25 Jan 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months
High Decrease in 1 Year High Decrease in 1 Year
Doji and Near Doji Doji and Near Doji

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,042.00 +0.2%
Divi's Laboratories Ltd. 88,552.35 3,361.15 +0.8%
Cipla Ltd. 83,862.25 1,039.35 +0.4%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,297.00 +2.3%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,224.45 0.0%
Torrent Pharmaceuticals Ltd. 52,497.96 1,530.85 -1.7%
Abbott India Ltd. 45,101.64 21,177.10 -0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,042.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,361.15 +0.8%
Cipla Ltd. Consolidated 2022-09 32.68 1,039.35 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,297.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,224.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,530.85 -1.7%
Abbott India Ltd. Standalone 2022-09 51.15 21,177.10 -0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,042.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,361.15 +0.8%
Cipla Ltd. Consolidated 2022-09 3.83 1,039.35 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,297.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,224.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,530.85 -1.7%
Abbott India Ltd. Standalone 2022-09 16.62 21,177.10 -0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,042.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,361.15 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,039.35 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,297.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,224.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,530.85 -1.7%
Abbott India Ltd. Standalone 2022-03 0.00 21,177.10 -0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,042.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,361.15 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,039.35 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,224.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,530.85 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 21,177.10 -0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,042.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,361.15 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,039.35 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,297.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,224.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,530.85 -1.7%
Abbott India Ltd. Standalone 2022-03 29.95 21,177.10 -0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,042.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,361.15 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,039.35 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,297.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,224.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,530.85 -1.7%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,177.10 -0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,042.00 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,361.15 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,039.35 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,297.00 +2.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,224.45 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,530.85 -1.7%
Abbott India Ltd. Standalone 2022-03 798.70 21,177.10 -0.5%

FAQ's On Wanbury Ltd.

What is Wanbury share price?
Can I buy Wanbury shares now?
What is the Market Cap of Wanbury?
What are the key metrics to analyse Wanbury?
What is the 52 Week High and Low of Wanbury?
What is the trend of Wanbury share price?